Calumet Inc. (NASDAQ: CLMT) is a Basic Materials company in the Chemicals - Specialty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -2.16 | Insider Own | 20.39% | Shs Outstand | 87.15M | Perf Week | 6.00% |
| Market Cap | 3.85B | Forward P/E | 36.84 | EPS next Y | 1.20 | Insider Trans | -3.57% | Shs Float | 58.41M | Perf Month | 21.30% |
| Enterprise Value | 6.21B | PEG | 0.03 | EPS next Q | - | Inst Own | - | Short Float | 6.27% | Perf Quarter | 35.06% |
| Income | -189.09M | P/S | 0.92 | EPS this Y | 6.05% | Inst Trans | - | Short Ratio | 3.89 | Perf Half Y | 97.36% |
| Sales | 4.17B | P/B | - | EPS next Y | 159.11% | ROA | -6.85% | Short Interest | 3.66M | Perf YTD | 122.40% |
| Book/sh | - | P/C | 28.84 | EPS next 5Y | - | ROE | 21.70% | 52W High | 43.34 -2.23% | Perf Year | 173.96% |
| Cash/sh | - | P/FCF | 45.09 | EPS past 3/5Y | - | ROIC | -0.43% | 52W Low | 12.41 241.50% | Perf 3Y | 168.80% |
| Dividend Est. | - | EV/EBITDA | - | Sales past 3/5Y | -4.07% 12.77% | Gross Margin | 5.74% | Volatility | 3.15% 3.83% | Perf 5Y | 536.74% |
| Dividend TTM | - | EV/Sales | 1.49 | EPS Y/Y TTM | 19.10% | Oper. Margin | -0.30% | ATR (14) | 1.60 | Perf 10Y | 789.13% |
| Dividend Ex-Date | Jan 29, 2016 | Quick Ratio | 0.58 | Sales Y/Y TTM | -0.36% | Profit Margin | -4.52% | RSI (14) | 72.28 | Recom | 2.83 |
| Dividend Gr. 3/5Y | -36.69% -18.80% | Current Ratio | 0.96 | EPS Q/Q | -253.40% | SMA20 | 7.29% | Beta | 0.74 | Target Price | 33.00 |
| Payout | 0.00% | Debt/Eq | - | Sales Q/Q | 3.62% | SMA50 | 18.67% | Rel Volume | 0.75 | Prev Close | 44.19 |
| Employees | 1,540 | LT Debt/Eq | -4.60 | Earnings | Aug 07 | SMA200 | 57.07% | Avg Volume | 994.40K | Price | 42.37 |
| IPO Date | Jan 26, 2006 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -993.16% 2.86% | Net Debt/EBITDA | -53.92 | Volume | 742,102 | Change | -4.12% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-30-26 | Reiterated | Goldman Sachs | Neutral | $36 → $40 |
| Apr-24-26 | Reiterated | Goldman Sachs | Buy | $24 → $36 |
| Feb-13-26 | Reiterated | UBS | Neutral | $13 → $26 |
| Jan-30-26 | Reiterated | Goldman Sachs | Buy | $20 → $24 |
| Oct-22-25 | Reiterated | Goldman Sachs | Buy | $20 |
| Aug-12-25 | Reiterated | UBS | Neutral | $16 → $13 |
| Mar-17-25 | Upgrade | UBS | Sell → Neutral | |
| Mar-05-25 | Reiterated | Wells Fargo | Overweight | $29 → $28 |
| Feb-04-25 | Downgrade | UBS | Neutral → Sell | |
| Dec-14-22 | Reiterated | UBS | Neutral | $16 |
Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Performance Brands segment includes Royal Purple, Bel-Ray, and TruFuel. The Corporate segment focuses on the general and administrative expenses not allocated to other segments. The company was founded in 1919 and is headquartered in Indianapolis, IN.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,174 | 4,137 | 4,189 | 4,181 | 4,686 | 3,148 | 2,268 | 3,453 | 3,498 | |
| Cost of Goods Sold Incl. D&A | 3,933 | 3,891 | 3,959 | 3,729 | 4,335 | 3,005 | 2,169 | 3,001 | 3,061 | |
| Gross Profit | 240 | 246 | 231 | 452 | 352 | 143 | 99 | 452 | 437 | |
| Selling, General and Administrative Excl. Other | 225 | 172 | 201 | 188 | 197 | 204 | 139 | 313 | 318 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 27 | 20 | 22 | -3 | 23 | 25 | 32 | 62 | 1 | |
| Operating Income | -12 | 54 | 8 | 267 | 132 | -86 | -72 | 76 | 123 | |
| Interest Expense | 107 | 216 | 237 | 222 | 176 | 150 | 126 | 135 | 156 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -184 | 35 | 7 | 4 | -126 | -23 | 50 | 15 | -18 | |
| Net Income Before Taxes | -303 | -126 | -221 | 50 | -170 | -259 | -148 | -43 | -50 | |
| Income Taxes | -114 | -93 | 1 | 2 | 3 | 2 | 1 | 1 | 1 | |
| Consolidated Net Income | -189 | -34 | -222 | 48 | -170 | -255 | -149 | -44 | -55 | |
| Net Income From Continuing Operations | -189 | -34 | -222 | 48 | -173 | -260 | -149 | -44 | -51 | |
| Net Income | -189 | -34 | -222 | 48 | -170 | -255 | -149 | -44 | -55 | |
| EPS (Recurring) | -2.16 | -0.39 | -2.67 | 0.59 | -2.14 | -3.23 | -1.86 | -0.56 | -0.71 | |
| EPS (Basic, Before Extraordinaries) | -2.16 | -0.39 | -2.67 | 0.59 | -2.14 | -3.23 | -1.86 | -0.56 | -0.71 | |
| EPS (Diluted) | -2.16 | -0.39 | -2.67 | 0.59 | -2.14 | -3.23 | -1.86 | -0.56 | -0.71 | |
| EBITDA | -44 | 238 | 165 | 418 | 104 | 16 | 83 | 202 | 236 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | 30.29 | — | — | — | — | — | |
| Price To Sales Ratio | 0.88 | 0.42 | 0.44 | 0.34 | 0.28 | 0.33 | 0.11 | 0.08 | 0.05 | |
| Gross Margin | 5.75 | 5.95 | 5.51 | 10.81 | 7.51 | 4.54 | 4.37 | 13.09 | 12.49 | |
| Operating Margin | -0.29 | 1.31 | 0.19 | 6.39 | 2.82 | -2.73 | -3.17 | 2.20 | 3.52 | |
| Net Margin | -4.53 | -0.82 | -5.30 | 1.15 | -3.63 | -8.10 | -6.57 | -1.27 | -1.57 | |
| Shares Outstanding | 87 | 87 | 83 | 80 | 79 | 79 | 78 | 78 | 78 | |
| Market Capitalization | 3,686 | 1,729 | 1,828 | 1,430 | 1,334 | 1,043 | 244 | 285 | 172 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Mawer Stephen P | Director | Jul 09 '26 | Option Exercise | 0.00 | 13,780 | 0 | 317,090 | Jul 13 |
| Raymond Paul C | Director | Jul 09 '26 | Option Exercise | 0.00 | 7,067 | 0 | 31,800 | Jul 13 |
| Sajkowski Daniel J | Director | Jul 09 '26 | Option Exercise | 0.00 | 7,067 | 0 | 84,785 | Jul 13 |
| Schumacher Amy M | Director | Jul 09 '26 | Option Exercise | 0.00 | 7,067 | 0 | 258,160 | Jul 13 |
| Quintana Julio M | Director | Jul 09 '26 | Option Exercise | 0.00 | 7,067 | 0 | 7,067 | Jul 13 |
| Boss John G. | Director | Jul 09 '26 | Option Exercise | 0.00 | 7,067 | 0 | 35,860 | Jul 13 |
| NARWOLD KAREN G | Director | Jul 09 '26 | Option Exercise | 0.00 | 7,067 | 0 | 7,067 | Jul 13 |
| Twitchell Karen A. | Director | Jul 09 '26 | Option Exercise | 0.00 | 7,067 | 0 | 13,389 | Jul 13 |
| Sajkowski Daniel J | Director | Jul 01 '26 | Sale | 36.16 | 4,240 | 153,318 | 77,718 | Jul 02 |
| Heritage Group | 10 percent owner, other: 13(d) 10% Group Member | May 15 '26 | Option Exercise | 20.00 | 1,020,000 | 20,400,000 | 13,607,209 | May 19 |
| Heritage Group | 10 percent owner, other: 13(d) 10% Group Member | May 15 '26 | Sale | 32.54 | 626,998 | 20,400,007 | 12,980,211 | May 19 |
| Sajkowski Daniel J | Director | Apr 01 '26 | Sale | 34.46 | 3,310 | 114,063 | 81,958 | Apr 02 |
| Fleming Bruce A | EVP - MONTANA RENEWABLES | Mar 09 '26 | Option Exercise | 0.00 | 20,621 | 0 | 558,119 | Mar 11 |
| Obermeier Scott | EVP - SPECIALTIES | Mar 09 '26 | Option Exercise | 0.00 | 24,090 | 0 | 248,240 | Mar 11 |
| Morical Gregory J | SVP, GENERAL COUNSEL | Mar 09 '26 | Option Exercise | 0.00 | 15,348 | 0 | 54,763 | Mar 11 |